• About
    • Leadership
    • Medical Advisory Board
    • Conditions We Treat
    • Careers
  • Science
    • Product
    • Procedure
    • History
  • Clinical Trials
  • Press
    • Allotex in the News
    • Press Releases
    • Media Assets
  • Contact
  • Menu
  • Skip to right header navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Allotex

Allograft Inlays & Onlays

  • About
    • Leadership
    • Medical Advisory Board
    • Conditions We Treat
    • Careers
  • Science
    • Product
    • Procedure
    • History
  • Clinical Trials
  • Press
    • Allotex in the News
    • Press Releases
    • Media Assets
  • Contact
    • Twitter

David Muller, CEO

Prior to founding Allotex, Dr. Muller recognized the potential of a procedure known as corneal cross-linking and founded Avedro, Inc. The company successfully obtained FDA approval for the technology in 2016 and now it is available worldwide to treat keratoconus, an orphan indication which is often sight threatening. Earlier in his career, as the founder, Chairman of the Board and CEO of Summit Technology, he led the team that brought the first FDA-approved laser vision correction to the market. David holds an AB from Boston University, a doctorate in physical chemistry from Cornell University and an MBA from The Wharton School at the University of Pennsylvania.

Primary Sidebar

About

  • Leadership
  • Medical Advisory Board
  • Conditions We Treat
  • Careers

Footer

Contact

Allotex, Inc.
27-43 Wormwood Street
Suite 160
Boston MA 02210
617-391-9544

Copyright © 2014 - 2019 Allotex, Inc. · All Rights Reserved · Privacy Policy · Site design and development by Sky Dog Technologies